The veterinarians will base their assessment on the information gathered during the four stages of the diagnostic process. To establish a provisional prognosis, they may consider certain factors such as:

  • Age: In a study comparing a group of survivors and deceased individuals who received similar treatments, it was calculated that horses under 5.25 years old had an 87.1% risk of dying [1].
  • Standing:  This factor is described in several studies as a positive parameter for survival prognosis [3, 4].
  • Signs of pain: If severe and uncontrollable, they can be a reason for ethical euthanasia.
  • Affected muscle groups: Damage to the heart or respiratory muscles has a more significant impact on the prognosis than alterations to postural muscles.
  • Lactate level: A British study on hospitalized cases indicates that the lactate level could contribute to assessing the prognosis [2].
  • Total calcium level: Another study shows that the total calcium level significantly contributes to the prognosis [1].
  • Case progression: It was calculated that when a horse is still alive on the third day after the appearance of the first signs, it has a 50% chance of survival.

However, some parameters do not factor into the prognosis establishment:

  • CK level: This level is not correlated with the survival/death of the animal. In fact, a surviving horse presented one of the highest values of CK activity (7,000,000 IU/L) ever measured.
  • Blood level of hypoglycin A or MCPA-carnitine [1].

The final prognosis can only be determined with the analysis of acylcarnitine profiles, which reflects the significance of energy disturbances. In particular, acetylcarnitine (C2), decadienoylcarnitine (C10:2), and stearoylcarnitine (C18) allow for the calculation of a fairly robust survival prognosis [1, 5]. Recently, a study highlighted that isovalerylcarnitine (C5 carnitine) is the most discriminating parameter for confirming a diagnosis of atypical myopathy and establishing a survival prognosis [5].Unfortunately, this form of analysis is not currently a standard practice in veterinary medicine, and the process of obtaining such an analysis can be time-consuming.

 
+

Bibliography sources

1. Boemer, F., Detilleux, J., Cello, C., et al. Acylcarnitines profile best predicts survival in horses with atypical myopathy. 2017. PLoS One 12, e0182761. https://hdl.handle.net/2268/214327

2. Dunkel, B., Ryan, A., Haggett, E., et al. Atypical myopathy in the South-East of England: Clinicopathological data and outcome in hospitalized horses. Equine Veterinary Educ. 2018:6. doi: 10.1111/eve.12895 https://beva.onlinelibrary.wiley.com/doi/full/10.1111/eve.12895

3. Gonzalez Medina, S., Hyde, C., Lovera, I., et al. Detection of equine atypical myopathy-associated hypoglycin A in plant material: Optimization and validation of a novel LC-MS based method without derivatization. 2018. PLoS One 13, e0199521https://pubmed.ncbi.nlm.nih.gov/29969503/

4. van Galen, G., Saegerman, C., Marcillaud Pitel, C., et al. European outbreaks of atypical myopathy in grazing horses (2006-2009): Determination of indicators for risk and prognostic factors. Equine Vet. J. 2012;44:621-625 https://pubmed.ncbi.nlm.nih.gov/22413891/

5. Renaud B, Kruse CJ, François AC, Cesarini C, van Loon G, Palmers K, Boemer F, Luis G, Gustin P, Votion DM. Large-scale study of blood markers in equine atypical myopathy reveals subclinical poisoning and advances in diagnostic and prognostic criteria. Environ Toxicol Pharmacol. 2024 Jul 18;110:104515. doi: 10.1016/j.etap.2024.104515. Epub ahead of print. PMID: 39032580.
https://www.sciencedirect.com/science/article/pii/S1382668924001558?dgcid=author

updated on 11/28/24

Share this page

cookieImage